Skip to main content

Table 2 Expression of CD163 and CD206

From: Effects of irbesartan on phenotypic alterations in monocytes and the inflammatory status of hypertensive patients with left ventricular hypertrophy

 

Control (n = 30)

Non-LVH (n = 29)

LVH (n = 30)

F

P

CD163 (%)

87.75 ± 25.32

75.29 ± 18.30*

65.73 ± 17.89*#

13.18

< 0.001

CD206 (%)

32.32 ± 7.82

30.81 ± 8.29

12.19 ± 6.07*#

8.45

0.002

  1. *P < 0.05 versus control, #P < 0.05 versus non-LVH group
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us